文献速递妇科

辛二酰苯胺异羟肟酸抑制组蛋白脱乙酰酶:治疗人子宫平滑肌瘤的一种治疗途径

Histone deacetylase inhibition by suberoylanilide hydroxamic acid: a therapeutic approach to treat human uterine leiomyoma.
PubMed 文献 · Fertil Steril · 2021-11-19

本研究通过体外实验比较子宫平滑肌瘤与邻近肌层组织及细胞,发现平滑肌瘤中HDAC基因表达与活性显著升高;SAHA可降低肌瘤原代细胞HDAC活性、细胞活力及增殖、细胞周期、细胞外基质与TGF-β3信号相关指标,作者认为组蛋白脱乙酰化可能对治疗子宫平滑肌瘤有用。

要点

  • 子宫平滑肌瘤组织中HDAC1、HDAC3、HDAC6基因表达及HDAC活性较邻近肌层显著升高。
  • SAHA降低子宫平滑肌瘤原代细胞HDAC活性与细胞活力,但不降低邻近肌层细胞相应指标。
  • SAHA显著抑制肌瘤原代细胞增殖、细胞周期、细胞外基质蛋白及TGF-β3、MMP9基因表达。

核心结论

  • SAHA处理可抑制人子宫平滑肌瘤原代细胞的细胞增殖、细胞周期、细胞外基质形成及TGF-β3信号,作者认为组蛋白脱乙酰化可能对治疗子宫平滑肌瘤有用。

研究设计与样本

  • 前瞻性研究,比较子宫平滑肌瘤组织与细胞和邻近肌层组织与细胞,并比较有或无SAHA处理的条件。
  • 研究对象为未接受任何激素治疗的子宫平滑肌瘤女性,干预为因肌瘤疾病行子宫肌瘤剔除术或子宫切除术。
  • 设置包括医院和大学实验室。

主要发现

  • 子宫平滑肌瘤组织较邻近肌层组织HDAC1基因表达倍数变化为1.65、HDAC3为2.08、HDAC6为2.42,HDAC活性为0.56 vs 0.10 OD/h/mg。
  • SAHA降低人子宫平滑肌瘤原代细胞HDAC活性但不降低邻近肌层细胞HDAC活性。
  • 人子宫平滑肌瘤原代细胞活力在5 μM SAHA时为81.68%、10 μM SAHA时为73.46%,邻近肌层细胞活力未显著降低。
  • SAHA处理的人子宫平滑肌瘤原代细胞中增殖细胞核抗原表达在5 μM SAHA时倍数变化为0.556、10 μM时为0.622,均显著受抑。
  • SAHA处理后细胞周期标志物C-MYC(5 μM SAHA,倍数变化0.828)和CCND1(5 μM SAHA,倍数变化0.583;10 μM SAHA,倍数变化0.482)显著下调。

关键数值与推荐

  • SAHA显著抑制人子宫平滑肌瘤原代细胞细胞外基质蛋白表达:FIBRONECTIN在5 μM SAHA时倍数变化0.815、10 μM时0.673;COLLAGEN I在5 μM SAHA时0.599、10 μM时0.635。
  • 10 μM SAHA显著下调TGFβ3基因表达(倍数变化0.596)和MMP9基因表达(倍数变化0.677)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the effect of inhibition of histone deacetylases (HDACs) by suberoylanilide hydroxamic acid (SAHA) treatment of human uterine leiomyoma primary (HULP) cells in vitro on cell proliferation, cell cycle, extracellular matrix (ECM) formation, and transforming growth factor β3 (TGF-β3) signaling. DESIGN: Prospective study comparing uterine leiomyoma (UL) vs. adjacent myometrium (MM) tissue and cells with or without SAHA treatment. SETTING: Hospital and university laboratories. PATIENT(S): Women with UL without any hormone treatment. INTERVENTION(S): Myomectomy or hysterectomy surgery in women for leiomyoma disease. MAIN OUTCOME MEASURE(S): HDAC activity was assessed by enzyme-linked immunosorbent assay, and gene expression was assessed by quantitative real-time polymerase chain reaction. Effects of SAHA on HULP cells were analyzed by CellTiter (Promega, Madison, Wisconsin), Western blot, and quantitative real-time polymerase chain reaction. RESULT(S): The expression of HDAC genes (HDAC1, fold change [FC] = 1.65; HDAC3, FC = 2.08; HDAC6, FC = 2.42) and activity (0.56 vs. 0.10 optical density [OD]/h/mg) was significantly increased in UL vs. MM tissue. SAHA decreased HDAC activity in HULP cells but not in MM cells. Cell viability significantly decreased in HULP cells (81.68% at 5 μM SAHA, 73.46% at 10 μM SAHA), but not in MM cells. Proliferating cell nuclear antigen expression was significantly inhibited in SAHA-treated HULP cells (5 μM SAHA, FC = 0.556; 10 μM SAHA, FC = 0.622). Cell cycle markers, including C-MYC (5 μM SAHA, FC = 0.828) and CCND1 (5 μM SAHA, FC = 0.583; 10 μM SAHA, FC = 0.482), were significantly down-regulated after SAHA treatment. SAHA significantly inhibited ECM protein expression, including FIBRONECTIN (5 μM SAHA, FC = 0.815; 10 μM SAHA, FC = 0.673) and COLLAGEN I (5 μM SAHA, FC = 0.599; 10 μM SAHA, FC = 0.635), in HULP cells. TGFβ3 and MMP9 gene expression was also significantly down-regulated by 10 μM SAHA (TGFβ3, FC = 0.596; MMP9, FC = 0.677). CONCLUSION(S): SAHA treatment inhibits cell proliferation, cell cycle, ECM formation, and TGF-β3 signaling in HULP cells, suggesting that histone deacetylation may be useful for treatment of UL.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Carbajo-García MC, García-Alcázar Z, Corachán A, et al. Histone deacetylase inhibition by suberoylanilide hydroxamic acid: a therapeutic approach to treat human uterine leiomyoma. Fertil Steril. 2021. PMID: 34809976. doi:10.1016/j.fertnstert.2021.10.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。